The Three Dimensional Conformal Radiotherapy for Hyperkeratotic Plantar Mycosis Fungoides
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The localized early-stage of Mycosis fungoides (MF) (stage IA-IIA) is usually treated with topical agents, such as nitrogen mustard, steroids, and phototherapy (UVB/PUVA) as first line therapy; response to these initial treatments is usually good. However, hyperkeratotic plantar lesions are clinically rare and have decreased responsiveness to topical agents. For such cases, physicians may consider local radiotherapy. Here, a case of an 18-year-old Korean woman who was treated with three-dimensional conformal radiotherapy (3D-CRT) for hyperkeratotic plantar lesions that were refractory to UVA-1, methotrexate, and topical steroids is reported. Complete remission was attained after radiotherapy. During the one-year follow-up period, there has been no evidence of disease recurrence and no chronic complications have been observed. (Ann Dermatol 23(S1) S57∼S60, 2011)
Abstract
The localized early-stage of Mycosis fungoides (MF) (stage IA-IIA) is usually treated with topical agents, such as nitrogen mustard, steroids, and phototherapy (UVB/PUVA) as first line therapy; response to these initial treatments is usually good. However, hyperkeratotic plantar lesions are clinically rare and have decreased responsiveness to topical agents. For such cases, physicians may consider local radiotherapy. Here, a case of an 18-year-old Korean woman who was treated with three-dimensional conformal radiotherapy (3D-CRT) for hyperkeratotic plantar lesions that were refractory to UVA-1, methotrexate, and topical steroids is reported. Complete remission was attained after radiotherapy. During the one-year follow-up period, there has been no evidence of disease recurrence and no chronic complications have been observed. (Ann Dermatol 23(S1) S57∼S60, 2011)
참고문헌 (10)
- Whittaker SJ, "British Association of Dermatologists; U.K. Cutaneous Lymphoma Group. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas", Br J Dermatol, 149, pp.1095~1107 (2003)
- Siegel RS, "Primary cutaneous T-cell lymphoma: review and current concepts", J Clin Oncol, 18, pp.2908~2925 (2000)
- Kneitz H, "Mycosis fungoides bullosa: a case report and review of the literature", J Med Case Reports, 4, pp.78~ (2010)
- Duvic M, "Emerging new therapies for cutaneous T-cell lymphoma", Dermatol Clin, 18, pp.147~156 (2000)
- Pandya MJ, "Unusual presentation of T-cell lymphoma", Indian J Dermatol Venereol Leprol, 63, pp.370~372 (1997)
- Jacob R, "A case of syringotropic cutaneous T-cell lymphoma treated with local radiotherapy", J Am Acad Dermatol, 60, pp.152~154 (2009)
- Curt H, "Cutaneous T-cell lymphoma. In Perez and Brady's principles and practice of radiation oncology. 5th ed", pp.1766~1776 (2007), Philadelphia: Lippincott Williams & Wilkins
- Samant RS, "Total scalp radiation using image-guided IMRT for progressive cutaneous T-cell lymphoma", Br J Radiol, 82, pp.122~125 (2009)
- Eich HT, "Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma", Int J Radiat Oncol Biol Phys, 55, pp.899~906 (2003)
- Purdy JA, "Three-dimensional conformal radiation therapy: physics, treatment planning, and clinical aspects. In Perez and Brady's principles and practice of radiation oncology. 5th ed", pp.218~238 (2007), Philadelphia: Lippincott Williams & Wilkins